18.227.114.218
dgid:
enl:
npi:0
-Advertisement-
Geographic Atrophy
Study links levodopa use to reduced risk of geographic atrophy in AMD
Standard and ultrawide field imaging show similar geographic atrophy progression but differ in size measurements
Study highlights 25-year diagnostic delay in patients with cerebrotendinous xanthomatosis
FDA accepts Aldeyra’s NDA for reproxalap, sets PDUFA date for April 2025
Will OTX-TKI change the treatment landscape for neovascular AMD?
Geographic Atrophy
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-

Polls & Quizzes

Advances in glaucoma interventions: test your knowledge
Nov 18, 2024

Podcast Series

Who’s the right patient for iDose TR (travoprost intracameral implant) 75 mcg?
Nov 05, 2024

Quizzes

Advances in glaucoma interventions: test your knowledge
Nov 18, 2024

Videos

Dr. Ted Maddess highlights the novel, FDA-cleared objectiveField Analyzer
Nov 19, 2024
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-